Poultry
xClose

Loading ...
Swine
xClose

Loading ...
Dairy & Ruminant
xClose

Loading ...
Aquaculture
xClose

Loading ...
Feed
xClose

Loading ...
Animal Health
xClose

Loading ...
Animal Health


March 19, 2019

 

US regulator clears way for production of GE salmon 

 

 

In the near future, consumers in the US may get to buy and eat the country's first genetically engineered animal approved by regulators for human consumption-the AquAdvantage Salmon.

 

The US Food and Drug Administration (FDA) has finally approved the importation of eggs needed to produce the GE salmon, paving the way for its production by AquaBounty Technologies in its facility in Indiana.

 

It will be recalled that the FDA approved the application of AquaBounty to farm the GE AquAdvantage Salmon at a land-based, contained facility near Albany, Indiana, almost a year ago in April 2018. However, AquaBounty could not import the needed salmon eggs pending the publication of the final rules regarding product labelling, as required by the Appropriations Act.

 

As it announced the lifting of the alert raised against the importation of salmon eggs on Friday, March 8, the FDA noted that the product labelling issue was resolved with the US Department of Agriculture's issuance of a final regulation in late 2018, which will require companies to disclose when a food is bioengineered. Implementation of the regulation starts in 2020, according to an Associated Press report.

 

AquAdvantage Salmon is an Atlantic salmon that reaches market size faster than non-GE farm-raised Atlantic salmon. It was approved for production and human consumption by the FDA on November 19, 2015, after a thorough scientific review over a period of 20 years. The FDA has found AquAdvantage Salmon to be as safe and nutritious to eat as any non-GE Atlantic salmon.

 

AquAdvantage Salmon eggs are produced in the Massachusetts-based aquaculture company's facility in Canada.-Rick Alberto
 
AquAdvantage Salmon                                       PHOTO FROM FDA.GOV
Share this article on FacebookShare this article on TwitterPrint this articleForward this article
Previous
My eFeedLink last read